Adhesion Barrier Market Analysis

  • Report ID: 4535
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Adhesion Barrier Market Segmentation:

Formulation Segment Analysis

The film/mesh segment in the adhesion barrier market is estimated to gain a robust revenue share of 35% in the coming years owing to the rising surgical procedures. The most prevalent kind of adhesion barrier, film formulations are constructed of a thin, flexible material that is positioned in between the organs and tissues during surgery and can be implanted in a patient by themselves as anti-adhesive barriers to prevent adhesions after surgery. According to estimates, in 2021, non-surgical operations rose by over 40% while surgical procedures rose by more than 50%.

Additionally, the gel segment is poised to garner significant market share during the forecast timeframe. Adhesion barrier gel serves as a barrier to stop or lessen post-surgical adhesions since it is sterile, clear, and highly viscous preventing fibroblast migration. It improves patient rehabilitation and is often used by gynecologists after surgical hysteroscopy in infertile women to reduce the creation of new adhesions.

Product Segment Analysis

Adhesion barrier market from the synthetic adhesion barriers segment is set to garner a notable share shortly. Synthetic adhesion barriers have become more and more popular in a variety of surgical procedures, including abdominal, gynecological, and cardiovascular surgeries as they are naturally able to contain a sizable amount of moisture, and are more efficient and safe for use in manufacturing. Moreover, synthetic adhesion barriers are more cost-effective and commercially available. Besides this, the natural adhesion barriers segment is anticipated to garner a significant share by the year 2035. Natural adhesion barriers are biologically sourced and they appear to sustain more potent anti-adhesion effects on oozing surfaces.

Application Segment Analysis

The cardiovascular surgeries segment in the adhesion barrier market is estimated to gain a robust revenue share in the coming years. Since more than 40 years ago, adhesion barriers have been employed in cardiac surgery as they frequently result in postoperative intrapericardial adhesion, which raises the danger of consequences such as organ damage, and hemorrhage. Moreover, adhesions around the heart may make a second cardiac surgery more difficult therefore, in cases where a future reoperation is expected, the use of an adhesion barrier is advised.

Furthermore, the gynecological surgeries segment in the adhesion barrier market is expected to witness substantial growth during the forecast timeframe. After gynecological operations, a variety of anti-adhesive barriers can be applied as adhesion formation during gynecologic procedures is common and extremely problematic since it immediately causes difficulties and makes subsequent surgery more challenging.

Our in-depth analysis of the global adhesion barrier market includes the following segments:

                             Product

  • Synthetic Adhesion Barriers
  • Natural Adhesion Barriers

                             Formulation

  • Film/Mesh
  • Gel
  •  Liquid

                              Application

  • Gynecological Surgeries
  • Abdominal General Surgeries
  • Orthopedic Surgeries
  • Cardiovascular Surgeries
  • Neurological Surgeries
  •  Urological Surgeries

                             End-User

  • Hospitals
  • Clinics
  •  Ambulatory Surgical Centers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of adhesion barrier is assessed at USD 990.75 million.

The global adhesion barrier market size surpassed USD 930.46 million in 2025 and is projected to witness a CAGR of over 7.2%, crossing USD 1.86 billion revenue by 2035.

The North America adhesion barrier market will hold over 36% share by 2035, driven by rising healthcare spending and demand for advanced medical technologies.

Key players in the market include Becton Dickinson and Company, Baxter International, Inc., Johnson & Johnson, Anika Therapeutic, Inc., FzioMed, Inc., Mast Biosurgery, Inc., Innocoll Holdings PLC, Atrium Medical Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos